Serotonin News and Research

Latest Serotonin News and Research

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Exploring the use of psychedelics as novel treatments for psychiatric disorders

Psychedelic compounds such as psilocybin, a substance found in various mushroom species, are garnering more research support as novel treatments for psychiatric disorders, but questions remain concerning who they may help the most.

13 Nov 2023

Study suggests concomitant antidepressant and statin use could prevent treatment discontinuation

A recent study in the journal BMC Medicine evaluates the real-world impact of combining antidepressants with statins in UK adults, revealing lower discontinuation rates but similar efficacy compared to antidepressant-only treatment.

12 Nov 2023

Pharmacogenomics holds promise for personalized dementia therapies

Pharmacogenomics-based studies in the research for personalized therapeutics for dementia

8 Nov 2023

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

The interactions between the gut microbiome, lipids, and Alzheimer’s disease (AD).

7 Nov 2023

Study sheds light on seasonal trends in adolescent depression and antidepressant prescribing

Researchers determined seasonal patterns in primary care antidepressant prescribing and consultations for mental health issues in adolescents and young adults living in England, United Kingdom (UK).

6 Nov 2023

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Dutch study finds SSRIs significantly alleviate post-COVID syndrome symptoms, offering promising treatment avenues and shedding light on neurobiological mechanisms at play.

5 Nov 2023

Scientists determine structure of key protein in neuronal communication

Neurons talk to each other using chemical signals called neurotransmitters. Scientists at St. Jude Children's Research Hospital have drawn on structural biology expertise to determine structures of vesicular monoamine transporter 2 (VMAT2), a key component of neuronal communication.

2 Nov 2023

Managing menopause: The 2023 toolkit for healthcare practitioners

The authors of the revised 2023 Toolkit extracted key recommendations from professional guidelines and positions as well as consensus statements on menopause and related conditions that have emerged since 2014.

1 Nov 2023

Imperial researchers discover hidden mechanism behind feeling touch

Imperial researchers have discovered a hidden mechanism within hair follicles that allow us to feel touch.

27 Oct 2023

New method provides valuable insights into the brain's noradrenaline system

An international team of researchers has provided valuable insights into the brain's noradrenaline (NA) system, which has been a longtime target for medications to treat attention-deficit/hyperactivity disorder, depression, and anxiety.

24 Oct 2023

Low serotonin levels observed in long COVID and other viral infections

Researchers identify a pathophysiological mechanism linking serotonin reduction to the multifaceted etiology of post-acute sequelae of COVID-19.

20 Oct 2023

How the gut microbiome contributes to schizophrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

19 Oct 2023

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

19 Oct 2023

Study links long COVID to gut inflammation and serotonin deficiency

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

16 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Researchers in neuropsychopharmacology challenge conventional wisdom about antidepressants' actions, revealing significant intracellular activity that influences their effectiveness. Utilizing advanced technologies, the study prompts a reevaluation of drug targeting and mechanisms, opening new avenues for treating depression.

12 Oct 2023

Research explains the reason behind delay in therapeutic action of antidepressants

SSRI antidepressants normally take a few weeks before any showing mental health benefits, but how come it takes so long? Now a study from a group of clinicians and scientists provides the first human evidence that this is due to physical changes in the brain leading to greater brain plasticity developing over the first few weeks of SSRI intake.

9 Oct 2023

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Intrusive thoughts, involuntary repetition of undesirable gestures and behaviors combined with high anxiety... Obsessive-compulsive disorder (OCD), a disabling condition, affects around 2% of the population, regardless of age.

9 Oct 2023

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Both severe depression and treatment-resistant depression are common. Up to one third of patients do not respond to conventional therapy with antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).

5 Oct 2023

Serotonin News and Research

Latest Serotonin News and Research

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Exploring the use of psychedelics as novel treatments for psychiatric disorders

Study suggests concomitant antidepressant and statin use could prevent treatment discontinuation

Pharmacogenomics holds promise for personalized dementia therapies

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

Study sheds light on seasonal trends in adolescent depression and antidepressant prescribing

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Scientists determine structure of key protein in neuronal communication

Managing menopause: The 2023 toolkit for healthcare practitioners

Imperial researchers discover hidden mechanism behind feeling touch

New method provides valuable insights into the brain's noradrenaline system

Low serotonin levels observed in long COVID and other viral infections

How the gut microbiome contributes to schizophrenia

How do different organ microbiomes influence neuropsychiatric disorders?

Study links long COVID to gut inflammation and serotonin deficiency

Are migraines linked to gut health and chronic non-communicable diseases?

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Research explains the reason behind delay in therapeutic action of antidepressants

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Innovation in neuroscience drug discovery - eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Serotonin News and Research

Latest Serotonin News and Research

Innovation in neuroscience drug discovery - eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in